Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125265552 | 12526555 | 2 | F | 20160629 | 20160705 | 20160708 | EXP | PHHY2016BR091259 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160708 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125265552 | 12526555 | 1 | PS | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 20823 | TABLET | ||||||||||
| 125265552 | 12526555 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | QD | 0 | TRANS-THERAPEUTIC-SYSTEM | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125265552 | 12526555 | 1 | Dementia |
| 125265552 | 12526555 | 2 | Dementia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125265552 | 12526555 | OT |
| 125265552 | 12526555 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125265552 | 12526555 | Aggression | |
| 125265552 | 12526555 | Aspiration bronchial | |
| 125265552 | 12526555 | Dementia | |
| 125265552 | 12526555 | Pain | |
| 125265552 | 12526555 | Platelet count decreased | |
| 125265552 | 12526555 | Respiratory disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |